Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine

Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine

Background & Aims: Biliary tract tumors are uncommon but highly aggressive malignancies with poor survival outcomes. Due to their low incidence, research into effective therapeutics has been limited. Novel research platforms for pre-clinical studies are desperately needed. We sought to develop a...

Full description

Bibliographic Details
Main Authors: Jennifer L. Leiting, Stephen J. Murphy, John R. Bergquist, Matthew C. Hernandez, Tommy Ivanics, Amro M. Abdelrahman, Lin Yang, Isaac Lynch, James B. Smadbeck, Sean P. Cleary, David M. Nagorney, Michael S. Torbenson, Rondell P. Graham, Lewis R. Roberts, Gregory J. Gores, Rory L. Smoot, Mark J. Truty
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:JHEP Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555920300021

Internet

http://www.sciencedirect.com/science/article/pii/S2589555920300021

Similar Items